Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Heat Biologics Inc (NASDAQ: HTBX)

$0.86 USD $0.01 (1.18%)
Last Price $0.86
Net Change $0.01 (1.18%)
Bid $0.86
Ask Price $0.87
Open Price $0.87
Previous Close Price $0.85
High Price $0.87
Low Price $0.85
Number of Trades 652
Volume 358,720
Fifty Two Week High $3.35 (2016-11-29)
Fifty Two Week Low $0.4 (2016-05-13)
Average Daily Volume 1,295,268
Share Outstanding 28,500 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-15.15
Recent Earnings $
Annual EPS $-1.53
Last Quarter EPS $
Market Capitalization $0.02B
Insider Shareholders % 0.228%
Annual Revenue $0B
No. Shares Outstanding 28,500
Inst. Shareholder % 3.91%
Annual Net Income $0B
TTM Net Profit Margin $100.09
1-Year Return 19.72%
3-Year Return -87.29%
5-Year Return -91.12%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -15.15%
Dividends per Share $
Stock Split Ratio
Beta 0.84
Heat Biologics Inc. is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. The Company's products under development include HS-110 for the treatment of non-small cell lung cancer HS-410 for the bladder cancer treatment HS-310 to treat ovarian cancer and HS-510 for treating triple negative breast cancer. Heat Biologics Inc. is based in Chapel Hill North Carolina.

HTBX News & Stock Updates